Qingdao Haier Biomedical Co Ltd

600690.SS · Health Technology · Medical Specialties · CN

2,690 employees · haierbiomedical.com

About

Qingdao Haier Biomedical Co., Ltd. generates revenue by developing biotech products and providing biomedical low-temperature storage solutions that cover the whole temperature range. These solutions address scenarios such as sample safety, drug and reagent safety, vaccine safety, and blood safety. The firm also offers automatic, intelligent, and comprehensive upgrading based on user needs, alongside integrated solutions for Internet of Thing (IoT) scenarios that cover a variety of biosafety products. The company sells its products to domestic and overseas markets. This distribution strategy allows Qingdao Haier Biomedical Co., Ltd. to reach customers who require specialized storage and IoT-integrated biosafety equipment for their specific operational requirements in the biomedical sector.

Annual results

Reported figures, CNY · revenue up 2.0% in 2025

YearRevenueNet incomeNet marginFree cash flow
20252.3B250M10.7%—
20242.3B366M16.0%—
20232.3B406M17.8%—
20222.9B600M20.9%—
20212.1B845M39.8%—

Dividends per share

2026 0.33 CNY2025 0.47 CNY2024 0.52 CNY2023 0.45 CNY2022 0.50 CNY

600690.SS in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Qingdao Haier Biomedical Co Ltd are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Qingdao Haier Biomedical Co Ltd (600690.SS) — company profile and financials · MarketPulse